Groundbreaking Lymphatic Interventions and Drug Exploration
ARPA-H seeks innovative solutions for its GLIDE program, exploring lymphatic interventions and drug development; full details in ISO ARPA-H-SOL-24-111.
This grant is no longer accepting proposals
Advanced Research Projects Agency for Health has archived this opportunity.
Funder: Advanced Research Projects Agency for Health (ARPA-H)
Due Dates: December 12, 2024 (Updated Response Date) | April 30, 2025 (Updated Inactive Date)
Funding Amounts: Total funding approximately $50 million; awarded via cooperative agreements.
Summary: Supports innovative solutions for lymphatic system interventions and drug development under the GLIDE program.
Key Information: Open to a broad range of applicants including individuals, nonprofits, academic institutions, and for-profit organizations; emphasizes high-risk, high-reward biomedical research with transformative potential.
Description
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals for the Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) program through its Innovative Solutions Opening (ISO) ARPA-H-SOL-24-111. This program aims to accelerate the development of novel lymphatic system interventions and drug discovery efforts that can transform health outcomes. ARPA-H focuses on high-risk, high-reward biomedical research projects that traditional funding mechanisms may not pursue, with an emphasis on rapid translation from discovery to real-world impact within 3-5 years.
The GLIDE program seeks innovative approaches to understand, manipulate, and therapeutically target the lymphatic system, which plays a critical role in health and disease but remains underexplored. Proposals should present bold, transformative ideas that can lead to breakthrough technologies or therapies.
